Macroporous solid hard microneedles with embedded particulate drugs

Patent metadata

Field	Value
Publication number	US-12589229-B2
Application number	US-202318507889-A
Country	US
Kind code	B2
Filing date	Nov 13, 2023
Priority date	May 13, 2021
Publication date	Mar 31, 2026
Grant date	Mar 31, 2026

Abstract

The present disclosure provides microneedles and microneedle patches for transdermal drug delivery and methods of making and using the same. The microneedles are porous and contain a drug in particulate form within the pores.

First claim

The invention claimed is:

1 . A microneedle for delivering a drug, the microneedle comprising:
a solid material comprising:
a solidified form obtained from a flowable material; the flowable material comprising a resin and the drug in particulate form;
the solidified form comprising a resin matrix comprising a plurality of pores in the resin matrix formed by spatial exclusion imposed by the presence of the drug in particulate form, wherein the plurality of pores are interconnected and distributed throughout the solidified form, the drug in particulate form being contained within the plurality of pores; and
a sharp apex; wherein
the particulate form is a powder, the powder comprising particles having sizes below 100 micrometers in a largest dimension.

2 . The microneedle of claim 1 , wherein the drug is substantially solvent-free.

3 . The microneedle of claim 1 , wherein the drug is substantially water-free.

4 . The microneedle of claim 1 , wherein more than 90% of the pores are occupied by at least one drug particulate.

5 . The microneedle of claim 1 , wherein more than 95% of the pores are occupied by at least one drug particulate.

6 . The microneedle of claim 1 , wherein more than 99% of the pores are occupied by at least one drug particulate.

7 . The microneedle of claim 1 , wherein more than 99.9% of the pores are occupied by at least one drug particulate.

8 . The microneedle of claim 1 , wherein more than 90% of volume of the pores is occupied by the drug.

9 . The microneedle of claim 1 , wherein more than 95% of volume of the pores is occupied by the drug.

10 . The microneedle of claim 1 , wherein more than 99% of volume of the pores is occupied by the drug.

11 . The microneedle of claim 1 , wherein more than 99.9% of volume of the pores is occupied by the drug.

12 . The microneedle of claim 1 , wherein the resin comprises a curable polymeric material.

13 . The microneedle of claim 1 , wherein the microneedle has an axial length between about 0.5 mm and about 1.5 mm.

14 . The microneedle of claim 1 , wherein the solid material has a hardness between 40 Shore A to 90 Shore D.

15 . A device for delivering a drug, the device comprising two or more microneedles according to claim 1 .

16 . The microneedle of claim 2 , wherein more than 90% of the pores are occupied by at least one drug particulate.

17 . The microneedle of claim 3 , wherein more than 90% of the pores are occupied by at least one drug particulate.

18 . The microneedle of claim 2 , wherein more than 90% of volume of the pores is occupied by the drug.

19 . The microneedle of claim 3 , wherein more than 90% of volume of the pores is occupied by the drug.

20 . The microneedle of claim 1 , wherein the microneedle has a drug loading of at least 10 μg/35 nL.

21 . A microneedle drug delivery system for drug delivery via diffusion mediated by interstitial fluid, said microneedle drug delivery system comprising a solid material comprising:
a solidified form obtained from a flowable material, the flowable material comprising a resin and a drug in particulate form; and the solidified form comprising a resin matrix comprising a plurality of pores in the resin matrix formed by spatial exclusion imposed by the presence of the drug in particulate form, wherein the plurality of pores are interconnected and distributed throughout the solidified form, the drug in particulate form being contained within the plurality of pores; wherein the particulate form is a powder, the powder comprising particles having sizes below 100 micrometers in a largest dimension.

22 . A method of providing time-controlled delivery of a drug, said method comprising:
providing a solid material comprising a solidified form obtained from a flowable material, the flowable material comprising a resin and a drug in particulate form, the solid material comprising a resin matrix and a plurality of pores in the resin matrix formed by spatial exclusion imposed by the presence of the drug in particulate form, wherein the plurality of pores are interconnected and distributed throughout the solidified form; the drug being contained within the plurality of pores; and permitting the solid material to come into contact with a dermal environment that comprises interstitial fluid, such that interstitial fluid contacts the drug in particulate form, causing the drug to dissolve into the interstitial fluid; wherein the particulate form is a powder, the powder comprising particles having sizes below 100 micrometers in a largest dimension.

23 . A microneedle patch for transdermal drug delivery, comprising:
a solid microneedle formed from a flowable material comprising a biocompatible resin and a drug in particulate form, the solid microneedle comprising a resin matrix and a plurality of pores in the resin matrix formed by spatial exclusion imposed by the presence of the drug in particulate form, wherein the plurality of pores are interconnected and distributed throughout the microneedle, the drug being embedded in the pores of the microneedle, the microneedle having a mechanical strength sufficient to penetrate the epidermis of skin without breaking; and a conformable back substrate bonded to the microneedle; wherein the particulate form is a powder, the powder comprising particles having sizes below about 100 micrometers in a largest dimension.

24 . A method of manufacturing a microneedle for providing time-controlled delivery of a drug, said method comprising:
providing a flowable material comprising a resin and the drug in particulate form; curing the flowable material into a solid material comprising a solidified form obtained from the flowable material, the solidified form comprising a resin matrix and a plurality of pores in the resin matrix formed by spatial exclusion imposed by the presence of the drug in particulate form, wherein the plurality of pores are interconnected and distributed throughout the solid material; the drug in particulate form being contained with the plurality of pores, wherein the powder comprising particles having sizes below 100 micrometers in a largest dimension.

Assignees

• Tufts College

Inventors

• Sonkusale Sameer
• Sadeqi Aydin
• Rezaei Nejad Hojatollah
• Lombardo Jake
• Tzortzakis Konstantinos

Classifications

• A61M2037/0046

  Solid microneedles · CPC title

• A61M2037/0023

  Drug applicators using microneedles · CPC title

• A61M2207/00

  Methods of manufacture, assembly or production · CPC title

• A61M2037/0053

  Methods for producing microneedles · CPC title

• A61B17/205 Primary

  Vaccinating by means of needles or other puncturing devices · CPC title